CORRECTION article

Front. Oncol., 13 March 2024

Sec. Cancer Genetics

Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1390669

Corrigendum: LncRNA-AC02278.4 is a novel prognostic biomarker that promotes tumor growth and metastasis in lung adenocarcinoma

  • XC

    Xi Chen 1

  • FZ

    Fan Zhou 2

  • WR

    Wenjun Ren 3

  • JG

    Jishu Guo 4

  • XH

    Xiaobin Huang 1

  • JP

    Jun Pu 1*

  • XN

    Xiaoqun Niu 5*

  • XJ

    Xiulin Jiang 6*

  • 1. Department of Neurosurgery, The second Affiliated Hospital of Kunming Medical University, Kunming, China

  • 2. Hematology and Rheumatology Department, The Pu’er People’s Hospital, Pu’er, China

  • 3. Department of Cardiovascular Surgery, The First People’s Hospital of Yunnan Province, Kunming, China

  • 4. Institute for Ecological Research and Pollution Control of Plateau Lakes, School of Ecology and Environmental Sciences, Yunnan University, Kunming, China

  • 5. Department of Respiratory Medicine, Second Hospital of Kunming Medical University, Kunming, China

  • 6. Kunming College of Life Science, University of Chinese Academy of Sciences, Beijing, China

In the published article, an author name was incorrectly written as Xin Chen. The correct spelling is Xi Chen.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

lncRNA-AC02278.4, lung adenocarcinoma, prognosis, biomarker, cell proliferation, cell migration

Citation

Chen X, Zhou F, Ren W, Guo J, Huang X, Pu J, Niu X and Jiang X (2024) Corrigendum: LncRNA-AC02278.4 is a novel prognostic biomarker that promotes tumor growth and metastasis in lung adenocarcinoma. Front. Oncol. 14:1390669. doi: 10.3389/fonc.2024.1390669

Received

23 February 2024

Accepted

27 February 2024

Published

13 March 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2024

Updates

Copyright

*Correspondence: Xiulin Jiang, ; Xiaoqun Niu, ; Jun Pu,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics